Home

Welcome to Stanton Glantz blog

Commentary on tobacco, cannabis and public health

Latest from the Blog

White House OKs FDA moving forward on reducing nicotine in cigs; FDA can and should ban menthol ecigs now

On June 21, 2022, the Biden Administration announced that FDA would be moving forward to develop a product standard limiting nicotine in cigarettes and other combusted tobacco products to nonaddictive levels. FDA has been formally considering such a rule for a long time. In 2018, FDA solicited public comment on such a rule. At thatContinue reading “White House OKs FDA moving forward on reducing nicotine in cigs; FDA can and should ban menthol ecigs now”

FDA should finalize the proposed rule prohibiting characterizing flavors in cigars and make it effective 90 days after publication of the final rule

My colleagues and I submitted this public comment to FDA urging them not to extend the comment period for the rule ending flavored cigars, as the tobacco companies have requested. Using the FDA’s own analysis cutting the shortening the effective date by nine months (from one-year to 90-days) would prevent an additional 396,000 people fromContinue reading “FDA should finalize the proposed rule prohibiting characterizing flavors in cigars and make it effective 90 days after publication of the final rule”

FDA should not give the tobacco companies more time to submit public comments about the proposed rule ending characterizing flavors in cigars

My colleagues and I submitted this public comment to FDA urging them not to extend the comment period for the rule ending flavored cigars, as the tobacco companies have requested. According to the FDA’s own analysis granting the 3 month delay would cost 60 lives and an additional $1.17-$1.43 billion in costs. The industry hasContinue reading “FDA should not give the tobacco companies more time to submit public comments about the proposed rule ending characterizing flavors in cigars”

Get new content delivered directly to your inbox.

%d bloggers like this: